Apple Locking Horns with Agency in Australia over iPad Advertisements

Apple Locking Horns with Agency in Australia over iPad Advertisements

Apple has been under a lot of fire in Australia over its iPad, which was marketed stating that it works on both Wi-Fi and 4G. But in reality, the devices were not able to connect to the 4G networks in Australia. A day before the new iPad went on sale, the Australian Competition and Consumer Commission (ACC) contacted the company, stating their concerns regarding the product.

There are two commercial 4G standards. Australia uses the Mobile WiMAX 4G standard, whereas the US and Canada go with LTE, which is what Apple has been talking about. After the concerns were raised, Apple acknowledged the fact that it would publish some corrective advisement and even refund the money to people who bought the iPad. They also assured to email each and every person, stating that iPad is not compatible with Australia's 4G networks. However, it was not that simple. There is now a disagreement over the use of words with the agency, stating that apple should remove the word 4G from its advertisements as it misleads people.

Both the parties are firm on their actions with Apple, saying that it open to alteration of words, but won’t omit them as there is some truth in what they portray their product to do.

Region: 
General: 
Companies: 

Popular Stories

Flu vaccine is 48% effective this season: CDC

Flu vaccine has reduced the risk of infections in... Read More

Erosion of beaches will get worse: researchers warn

Portraying a gloomy picture of the future, the 2015... Read More

Rare rat-linked disease leaves 1 dead, 2 sickened in Bronx

A rare bacterial disease carried by rats has killed... Read More

Try drug-free remedies before resorting to medication for low back pain: ACP

People suffering low back pain should try drug-free... Read More

Pregnant inmate forced to deliver baby on jail cell floor

A Detroit-area sheriff has defended his staff over... Read More

Marathon Pharma to sell decades-old drug to treat DMD for $89,000

Marathon Pharmaceuticals will reportedly market... Read More